Skip to Main Content

Paper Details

Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics-Driven Machine Learning Approach.
Arthritis Care Res (Hoboken)
12
2022
160 SNPs, ATIC, Intergenic SNPs, Methotrexate, Pharmacogenomic, RA, Rheumatoid Arthritis, SNPs, methotrexate, patients, rheumatoid arthritis, rheumatoid factor, rs113798271, rs12446816, rs13385025, rs2372536, single-nucleotide polymorphisms
Author NameAffiliation
Cynthia S CrowsonMayo Clinic
John M DavisMayo Clinic
Paul P TakAcademic Medical Centre, University of Amsterdam
Leonid PadyukovKarolinska Institutet, Karolinska University Hospital
Paul EmeryUniversity of Leeds and NIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust
Ann W MorganUniversity of Leeds and NIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust
Liewei WangMayo Clinic
Richard M WeinshilboumMayo Clinic
  • 1 - 8

Datasets

Release 1.2